HERON THERAPEUTICS, INC. /DE/ Production Related Impairments or Charges
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Production Related Impairments or Charges of $1.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProductionRelatedImpairmentsOrCharges · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ production related impairments or charges for the quarter ending 2026-06-30 was $1.00M, a 100.00% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ production related impairments or charges for the quarter ending 2026-03-31 was $300.00K.
- HERON THERAPEUTICS, INC. /DE/ production related impairments or charges for the quarter ending 2025-09-30 was $2.20M, a 175.00% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ production related impairments or charges for the quarter ending 2025-06-30 was $500.00K, a 68.75% decline year-over-year.
| Period end | Production Related Impairments or Charges 3 month | Production Related Impairments or Charges 6 month | Production Related Impairments or Charges 9 month |
|---|---|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-10 | $1.30M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-11 | ||
| 2025-09-30 | $2.20M 10-Q · filed 2025-11-04 | $2.70M derived: sum of 2 quarters · filed 2026-08-10 | $2.70M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $500.00K 10-Q · filed 2026-08-10 | $500.00K 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | ||
| 2024-09-30 | $800.00K 10-Q · filed 2025-11-04 | $2.40M derived: sum of 2 quarters · filed 2025-11-04 | $2.40M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $1.60M 10-Q · filed 2025-08-08 | $1.60M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | ||
| 2023-09-30 | $7.50M 10-Q · filed 2024-11-12 | $15.00M derived: sum of 2 quarters · filed 2024-11-12 | $20.30M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $7.50M 10-Q · filed 2024-08-06 | $12.80M 10-Q · filed 2024-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |